BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GENEWIZ, Inc. Expands Next Generation Sequencing Services With Cancer Panels


12/3/2012 12:11:47 PM

SOUTH PLAINFIELD, NJ--(Marketwire - December 03, 2012) -

GENEWIZ, Inc., leading global genomic service provider, announced today expansion of their Next Generation Sequencing service portfolio to include Cancer Panels. Available through Illumina and Life Technologies platforms, Cancer Panels enable GENEWIZ to screen for genetic mutations proven to play a role in cancer.

Advanced next generation sequencing technologies enable cancer panels to target over fifty cancer genes with deep sequencing, providing a high depth of coverage sensitive enough to detect rare mutations from a very small amount of DNA.

"NGS-based cancer panels allow for rapid analysis of multiple genes at a considerably lower price compared to traditional sequencing techniques," stated Dr. Yankai Jia, Director of GENEWIZ Next Generation Sequencing. "The large amount of data generated is highly technical, so it's important for researchers to have a trusted partner throughout the process who can provide the customized support and scientific expertise required."

In addition to offering the Ion AmpliSeq™ and TruSeq® Cancer Panels, GENEWIZ is actively developing custom cancer panels in effort to further advance cancer research, biomarker discovery, clinical diagnostics, and personalized medicine.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->